A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
Geoff D.E. Cuvelier(CancerCare Manitoba), Kirk R. Schultz(University of British Columbia), Michael A. Pulsipher(Primary Children's Hospital), Alexandra Cheerva(Kosair Children's Hospital), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Süreyya Savaşan(Children's Hospital of Michigan), Andrew C. Harris(Primary Children's Hospital), Emi Caywood(Alfred I. duPont Hospital for Children), Michael Joyce, Monica Bhatia(Columbia University Irving Medical Center), Eneida R. Nemecek(Oregon Health & Science University), Tal Schechter(Hospital for Sick Children), Sayeh Abdossamadi(University of British Columbia), Benjamin Oshrine(Johns Hopkins All Children's Hospital), Victor Lewis(Alberta Children's Hospital), Ánita Lawitschka(St Anna Children's Hospital), Sung Won Choi(University of Michigan), Bernard Ng(Rush University Medical Center), Carrie L. Kitko(Vanderbilt University Medical Center), David A. Jacobsohn(Children's National), Sonali Chaudhury(Northwestern University), Anna Pawłowska(City of Hope), Joseph H. Chewning(Kettering University), David Mitchell(Montreal Children's Hospital), Elena Ostroumov(University of British Columbia), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Gail Megason(University of Mississippi Medical Center), Alexis Melton(University of California, San Francisco), Donald W. Coulter(University of Nebraska Medical Center)
Cited by 26
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442